₹1,889.1
▲ +83.94 +4.65%
As of 27 Jul 2026 · delayed
NSE Listed
Dr. Lal Path Labs Ltd. (LALPATHLAB)
Volume: 21,06,413Avg Vol 1W: 8,04,799.6Avg Vol 1M: 4,64,795.352W Range:₹1,272.6₹1,894.9
Key Ratios
Checked 1d agoMarket Cap₹30,468 Cr
Current Price₹1,889.1
Previous Close₹1,805.16
High / Low (52w)₹1,894.9 / ₹1,272.6
Volume21,06,413
Avg Vol (1W)8,04,799.6
Avg Vol (1M)4,64,795.3
Stock P/E231.23
Book Value₹149.65
Dividend Yield1.5%
ROE20.1%
ROA16.2%
Revenue (TTM)₹2,864 Cr
Revenue Growth10.5%
Profit Margin18.3%
Total Debt₹0 Cr
Shares Outstanding17 Cr
Face Value₹10
EPS (TTM)₹7.86
P/B12.14
Debt / Equity0.08
50 DMA₹1,653.54
200 DMA₹1,509.4
Day change+4.65%
Price Chart
₹1,889.1▲ 24.85% · 1Y
2025-07-292026-07-27
20-day avg volume: 4.6L shares
Pros
- Healthy return on equity of 20.1%.
- Pays a dividend yield of 1.5%.
- Company is almost debt-free.
Cons
- Stock trades at a high P/E of 231.
Quarterly Results
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹660 Cr | ₹597 Cr | ₹603 Cr | ₹670 Cr | ₹731 Cr | ₹660 Cr | ₹703 Cr | ₹798 Cr |
| EBITDA | ₹189 Cr | ₹144 Cr | ₹158 Cr | ₹186 Cr | ₹208 Cr | ₹162 Cr | ₹166 Cr | ₹235 Cr |
| Net Profit | ₹129 Cr | ₹97 Cr | ₹155 Cr | ₹132 Cr | ₹151 Cr | ₹91 Cr | ₹131 Cr | ₹170 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹2,555 Cr | ₹577 Cr | ₹641 Cr | ₹700 Cr | ₹632 Cr | ₹675 Cr | ₹2,864 Cr | ₹764 Cr |
| EBITDA | ₹647 Cr | ₹150 Cr | ₹177 Cr | ₹199 Cr | ₹160 Cr | ₹176 Cr | ₹722 Cr | ₹228 Cr |
| Net Profit | ₹487 Cr | ₹148 Cr | ₹129 Cr | ₹146 Cr | ₹92 Cr | ₹141 Cr | ₹505 Cr | ₹166 Cr |
| EPS | 58.4 | — | — | — | — | — | 30.2 | — |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹1,091 Cr | ₹1,374 Cr | ₹1,661 Cr | ₹2,353 Cr | ₹2,386 Cr | ₹2,456 Cr | ₹2,717 Cr | ₹3,146 Cr |
| Total Liabilities | ₹140 Cr | ₹320 Cr | ₹385 Cr | ₹810 Cr | ₹686 Cr | ₹571 Cr | ₹510 Cr | ₹605 Cr |
| Equity | ₹951 Cr | ₹1,054 Cr | ₹1,276 Cr | ₹1,544 Cr | ₹1,700 Cr | ₹1,885 Cr | ₹2,206 Cr | ₹2,541 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹323 Cr | ₹377 Cr | ₹500 Cr | ₹577 Cr | ₹562 Cr | ₹667 Cr | ₹733 Cr | ₹811 Cr |
| Investing | ₹-100 Cr | ₹-26 Cr | ₹-212 Cr | ₹-449 Cr | ₹-287 Cr | ₹-24 Cr | ₹-303 Cr | ₹-422 Cr |
| Financing | ₹-55 Cr | ₹-190 Cr | ₹-139 Cr | ₹136 Cr | ₹-283 Cr | ₹-414 Cr | ₹-334 Cr | ₹-264 Cr |
| Free Cash Flow | ₹323 Cr | ₹377 Cr | ₹500 Cr | ₹577 Cr | ₹562 Cr | ₹667 Cr | ₹733 Cr | ₹811 Cr |
Shareholding
Promoter 53.19% Institutions 38.95% Public 7.86%
Efficiency & Working Capital
ROCE29.7%
Interest Coverage30.4
Dividend Payout—
Debtor Days15 d
Inventory Days6 d
Payable Days24 d
Cash Conversion Cycle-3 d
Working Capital Days20 d
Shareholding Details
As of 2026-06-30
Promoter53.2%
FII17.4%
DII21.6%
Institutions39%
Public7.9%
Promoter Pledge0%
No. of Shareholders1,11,037
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 54.6% | 54.6% | 54.6% | 54.6% | 53.9% | 53.9% | 53.9% | 53.8% | 53.2% | 53.2% | 53.2% | 53.2% |
| FIIs | 24.4% | 25.4% | 26.2% | 25.4% | 26.8% | 26.8% | 23.9% | 21.7% | 21.9% | 20.3% | 17.2% | 17.4% |
| DIIs | 8% | 8.6% | 9.7% | 12.7% | 12.9% | 13.2% | 16.1% | 17.9% | 18.5% | 19.2% | 21.4% | 21.6% |
| Public | 13.1% | 11.4% | 9.6% | 7.3% | 6.4% | 6.1% | 6.1% | 6.6% | 6.4% | 7.3% | 8.2% | 7.9% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 1,60,679 | 1,49,901 | 1,46,741 | 1,31,189 | 1,16,606 | 1,16,236 | 1,15,699 | 1,18,656 | 1,12,703 | 1,16,167 | 1,14,527 | 1,11,037 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Arvind Lal | Shareholding of Promoter and Promoter Group | 30.1% | 5.05 Cr |
| Vandana Lal | Shareholding of Promoter and Promoter Group | 19.2% | 3.22 Cr |
| Hdfc Mutual Fund - Hdfc Retirement Savings Fund - Equity Plan | Public Shareholding | 3.9% | 65,55,612 |
| Uti-mid Cap Fund | Public Shareholding | 2.6% | 44,30,364 |
| Nippon Life India Trustee Ltd-a/c Nippon India Pharma Fund | Public Shareholding | 2.6% | 44,15,617 |
| Anjaneya Lal | Shareholding of Promoter and Promoter Group | 2% | 33,79,228 |
| Smallcap World Fund, Inc | Public Shareholding | 2% | 33,17,603 |
| Archana Lal Erdmann | Shareholding of Promoter and Promoter Group | 1.8% | 30,87,502 |
| Aditya Birla Sun Life Trustee Private Limited A/c Aditya Birla Sun Life Small Cap Fund | Public Shareholding | 1.8% | 29,79,002 |
| Life Insurance Corporation Of India | Public Shareholding | 1.5% | 24,62,492 |
| Titanium Hybrid Long-short Fund | Public Shareholding | 1.4% | 23,64,311 |
| Sbi Nifty Smallcap 250 Etf | Public Shareholding | 1.4% | 23,24,583 |
| Invesco Oppenheimer International Growth Fund | Public Shareholding | 1.4% | 22,90,064 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Arvind Lal | Chairman/ED & CEO | 2026 |
| Vandana Lal | WTD & Executive Director | 2026 |
| Arun Duggal | Lead Independent Non Executive Director | 2026 |
| Rohit Bhasin | Independent Non Exe. Director | 2026 |
| Somya Satsangi | Independent Non Exe. Director | 2026 |
| Gurinder Singh Kalra | Independent Non Exe. Director | 2026 |
| RAJIT MEHTA | Independent Non Exe. Director | 2026 |
| Archana Lal Erdmann | Non Executive Director | 2026 |
| Rahul Sharma | Non Executive Director | 2026 |
| Vinay Gujral | Company Sec. & Compli. Officer | 2026 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Running laboratories for carrying o | ₹0 Cr | — |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| India | ₹2,615 Cr | 98.8% |
| Outside India | ₹32 Cr | 1.2% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹10 | 200 | 168 | 168 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| dividend | 2026-07-30 | ₹5 (50%) | Interim |
| forthcoming | 2026-07-30 | Dividend (5/- per share) | Interim |
| forthcoming | 2026-07-24 | Board Meetings | — |
| dividend | 2026-06-25 | ₹4.0 (40.0%) | Final |
| dividend | 2026-06-25 | ₹4 (40%) | Final |
| dividend | 2026-02-05 | ₹3.5 (35%) | Interim 3 |
| bonus | 2025-12-19 | 1:1 | 1:1 Bounus Issue of Equity Shares |
| dividend | 2025-11-07 | ₹7 (70%) | Interim 2 |
| dividend | 2025-08-06 | ₹6 (60%) | Interim |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 73 | 0 | 0 | 132 | 10 | 224 |
| 2026 | 0 | 0 | 0 | 0 | 10 | 10 |
| 2026 | 7 | 0 | 0 | 132 | 0 | 148 |
Insider / Designated-Person Trades
139 recent disclosure(s)
Reena NakraDisposal · 1,078
Prashant KishoreAcquisition · 872
Prashant KishoreDisposal · 600
Satish Kumar SinghAcquisition · 1,474
Dr. Lal PathLabs Employee Welfare TrustDisposal · 2,346
Abhishek MainiDisposal · 500
Substantial Acquisitions (SAST)
1 disclosure(s)
Market13/09/2024 · 1,57,500
Company Information
Incorporated1995
ChairmanArvind Lal
AuditorDeloitte Haskins & Sells LLP
Investor Email[email protected]
📍 E-2 Block Sector 18, Rohini, New Delhi, New Delhi, 110085
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search